Bayer today announced that its MEDRAD® Centargo multi-patient CT injector has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the use of compatible contrast agent ...
Follows recent FDA clearance to expand the use of compatible contrast agent presentations, adding single-dose vials in addition to Imaging Bulk Package presentations Radiology suites now have the ...
INDIANOLA, Pa., Dec. 19, 2019 /PRNewswire/ -- Bayer announced today the company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the indication of its MEDRAD ® ...
Centargo compatible with Ultravist® (iopromide), Isovue® (iopamidol), Optiray® (ioversol), Omnipaque™ (iohexol) and now, Visipaque™ (iodixanol) Follows recent FDA clearance to expand the use of ...
Contrast CT scans are performed to get a detailed image of the inside of your body and the blood vessels. Computed Tomography (CT) scans can be performed either with the contrast or without the ...
Anaphylaxis triggered by iodinated contrast media was rare, but severe and refractory cases indicated the need for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results